Cargando…
肺癌的免疫治疗临床研究进展
Lung cancer is a highly malignant disease with poor prognosis, most cases are diagnosed at a very late stage. More effective medications or therapies should be developed to improve its prognosis. The advancement of tumor immunity and tumor immunosuppression facilitated the feasibility of immunothera...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999828/ https://www.ncbi.nlm.nih.gov/pubmed/23075686 http://dx.doi.org/10.3779/j.issn.1009-3419.2012.10.08 |